Rani Therapeutics Holdings (RANI) Enterprise Value (2020 - 2025)
Rani Therapeutics Holdings (RANI) has 6 years of Enterprise Value data on record, last reported at -$8.3 million in Q3 2025.
- For Q3 2025, Enterprise Value fell 409.06% year-over-year to -$8.3 million; the TTM value through Sep 2025 reached -$8.3 million, down 409.06%, while the annual FY2024 figure was -$2.3 million, 133.68% down from the prior year.
- Enterprise Value reached -$8.3 million in Q3 2025 per RANI's latest filing, up from -$13.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at $17.2 million in Q3 2022 and bottomed at -$88.4 million in Q4 2022.
- Average Enterprise Value over 5 years is -$17.9 million, with a median of -$5.3 million recorded in 2024.
- Peak YoY movement for Enterprise Value: surged 135.66% in 2023, then tumbled 4870.77% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$43.3 million in 2021, then crashed by 104.07% to -$88.4 million in 2022, then surged by 107.6% to $6.7 million in 2023, then plummeted by 133.68% to -$2.3 million in 2024, then crashed by 265.19% to -$8.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$8.3 million in Q3 2025, -$13.8 million in Q2 2025, and -$12.4 million in Q1 2025.